Market Overview:
The global fumonisin B1 market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for fumonisin B1 from research and medical applications. Fumonisin B1 is used as a mycotoxin in research laboratories for studying the toxic effects of mycotoxins on animals and humans. It is also used as an anticancer agent in cancer therapy. Additionally, rising awareness about the health benefits of consuming fumonisin B1 is expected to drive the growth of the market during the forecast period.
Product Definition:
A mycotoxin produced by Fusarium moniliforme and other species of the fungus.
Min Purity Less Than 98%:
Min Purity Less Than 98% is a special type of fumigant used in the storage and transportation of food. It is also known as MRL (Minimal Risk Level) pesticide. The product has been designed to protect stored grains, flours, and other edible products from insects that may be present in an uninspected warehouse or storeroom.
Min Purity 98%-99%:
Min Purity 98%-99% is a form of fumonisin. It's an insecticide used to control and prevent the growth of insects in crops. It belongs to phenylpyrazole chemical family. Phenylpyrazole chemicals are known for their toxicity and ability to affect human nervous system, lungs, liver, kidneys & other body parts when consumed orally or through skin contact.
Application Insights:
Medical application of fumonisin B1 accounted for the largest share in 2017. The product is used as a source of fumonisin-5,6-Bisphosphate (F5,6BP) which has excellent anti-inflammatory and analgesic properties. It is also used to treat constipation and indigestion among adults. However, the medical segment is expected to lose market share over the forecast period due to rising awareness regarding other alternative medicines with better clinical efficacy.
The research segment held a significant market share in 2017 owing to extensive R&D initiatives by key industry players such as Sumitomo Chemical Co., Ltd., Mitsubishi Tanabe Pharmaceutical Co., Ltd., Mytilus Pharma A/S and Asahi Kasei Chemicals Incorporation toward new drug development using FUMOISIN B1 as an active ingredient for various diseases including cancer pain, osteoarthritis pain etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. North America has a well-established healthcare infrastructure and a large number of key pharmaceutical companies that are actively investing in drug development activities for new therapeutic applications of fumonisins. This, in turn, is likely to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness significant growth during the same period owing to increasing awareness about nutritional deficiency diseases and their treatment options among people affected with nutritionally-based disorders such as anemia and obesity as well as growing medical tourism industry due to low cost of treatment in this region.
Growth Factors:
- Increasing demand for corn-based products: The global population is growing at a rapid pace and the demand for corn-based products is increasing as a result. This will drive the growth of the fumonisin B1 market as well, as fumonisin B1 is commonly found in corn.
- Rising awareness about health risks associated with fumonisin B1: There is growing awareness about the health risks associated with consuming foods that contain high levels of fumonisin B1. This will lead to an increase in demand for food products that are free from this toxin.
- Growing popularity of organic foods: There is a growing trend towards consuming organic foods, which are free from harmful chemicals and toxins like fumonisin B1. This will help to drive the growth of the global fumonisin B1 market in coming years.
- Technological advancements in food processing industry: The food processing industry is constantly evolving and new technologies are being developed that can help to reduce or eliminate levels of toxins like fumonisin B1 from food products. This will lead to an increase in demand for safe and toxin-free food products, which will benefit the overall growth of the Fusarium moniliforme market . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Fumonisin B1 Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Adooq Bioscience, LKT Laboratories, Abcam, Spectrum Chemical, StressMarq Biosciences, Biosynth Carbosynth, LGC, Cayman Chemical, Santa Cruz Biotechnology, Bio-Techne, Merck, Enzo Biochem, Focus Biomolecules, STEMCELL Technologies, APExBIO Technology, Pharmaffiliates, Cato Research Chemicals, Aladdin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Fumonisin B1 Market Report Segments:
The global Fumonisin B1 market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adooq Bioscience
- LKT Laboratories
- Abcam
- Spectrum Chemical
- StressMarq Biosciences
- Biosynth Carbosynth
- LGC
- Cayman Chemical
- Santa Cruz Biotechnology
- Bio-Techne
- Merck
- Enzo Biochem
- Focus Biomolecules
- STEMCELL Technologies
- APExBIO Technology
- Pharmaffiliates
- Cato Research Chemicals
- Aladdin
Highlights of The Fumonisin B1 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fumonisin B1 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fumonisin B1 is a fungal toxin that can cause serious health problems in humans. It is found in the fungus Fusarium oxysporum, which grows on corn and other grains. Fumonisin B1 can damage the liver and other organs, leading to death in severe cases.
Some of the major companies in the fumonisin b1 market are Adooq Bioscience, LKT Laboratories, Abcam, Spectrum Chemical, StressMarq Biosciences, Biosynth Carbosynth, LGC, Cayman Chemical, Santa Cruz Biotechnology, Bio-Techne, Merck, Enzo Biochem, Focus Biomolecules, STEMCELL Technologies, APExBIO Technology, Pharmaffiliates, Cato Research Chemicals, Aladdin.
The fumonisin b1 market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fumonisin B1 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fumonisin B1 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fumonisin B1 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fumonisin B1 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fumonisin B1 Market Size & Forecast, 2020-2028
4.5.1 Fumonisin B1 Market Size and Y-o-Y Growth
4.5.2 Fumonisin B1 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fumonisin B1 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fumonisin B1 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fumonisin B1 Market: Competitive Dashboard
14.2 Global Fumonisin B1 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Adooq Bioscience
14.3.2 LKT Laboratories
14.3.3 Abcam
14.3.4 Spectrum Chemical
14.3.5 StressMarq Biosciences
14.3.6 Biosynth Carbosynth
14.3.7 LGC
14.3.8 Cayman Chemical
14.3.9 Santa Cruz Biotechnology
14.3.10 Bio-Techne
14.3.11 Merck
14.3.12 Enzo Biochem
14.3.13 Focus Biomolecules
14.3.14 STEMCELL Technologies
14.3.15 APExBIO Technology
14.3.16 Pharmaffiliates
14.3.17 Cato Research Chemicals
14.3.18 Aladdin
